[HTML][HTML] IGF-1R as an anti-cancer target—trials and tribulations

HX Chen, E Sharon - Chinese journal of cancer, 2013 - ncbi.nlm.nih.gov
Type I insulin-like growth factor receptor (IGF-1R) has long been recognized for its role in
tumorigenesis and growth, but only recently have the tools for targeting the IGF pathway …

Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

H Werner, R Sarfstein, I Bruchim - Expert opinion on investigational …, 2019 - Taylor & Francis
Introduction: The insulin-like growth factors (IGFs) are a family of secreted peptide hormones
with important roles in different cellular and organism functions. The biological activities of …

[HTML][HTML] IGF1R signalling and its inhibition

J Riedemann, VM Macaulay - Endocrine-related cancer, 2006 - erc.bioscientifica.com
The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase that is frequently
overexpressed by tumours, and mediates proliferation and apoptosis protection. IGF …

The insulin-like growth factor 1 receptor in cancer: old focus, new future

H Hartog, J Wesseling, HM Boezen… - European journal of …, 2007 - Elsevier
The importance of insulin-like growth factor 1 receptor (IGF-1R) signalling in malignant
behaviour of tumour cells is well established. Currently, development of drugs targeting the …

Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy

J Zha, MR Lackner - Clinical Cancer Research, 2010 - AACR
Signaling through the insulin-like growth factor receptor (IGF-1R) is required for neoplastic
transformation by a number of oncogenes, and preclinical validation studies have suggested …

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

EA Bohula, MP Playford, VM Macaulay - Anti-cancer drugs, 2003 - journals.lww.com
The type 1 insulin-like growth factor receptor (IGF1R) is overexpressed by many tumors, and
mediates growth, motility and protection from apoptosis. Inhibition of IGF1R expression or …

Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

E Buck, M Mulvihill - Expert opinion on investigational drugs, 2011 - Taylor & Francis
Introduction: The IGF-1 receptor (IGF-1R) is a receptor tyrosine kinase and is well
established as a key regulator of tumor cell growth and survival. There is also a growing …

[HTML][HTML] Targeting the insulin-like growth factor-1 receptor in human cancer

A Arcaro - Frontiers in pharmacology, 2013 - frontiersin.org
The insulin-like growth factor (IGF) signaling system plays a crucial role in human cancer
and the IGF-1 receptor (IGF-1R) is an attractive drug target against which a variety of novel …

Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?

A Gombos, O Metzger-Filho, L Dal Lago… - Investigational new …, 2012 - Springer
Insulin like growth factor receptor (IGF-1R) targeting became one of the most investigated
areas in anticancer drug development during the last decade. Strategies aiming to block IGF …

The type 1 insulin-like growth factor receptor pathway

MM Chitnis, JSP Yuen, AS Protheroe, M Pollak… - Clinical cancer …, 2008 - AACR
Research conducted over the past two decades has shown the importance of the type 1
insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to …